{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T21:51:05Z","timestamp":1759614665734,"version":"3.43.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41409-025-02602-5","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T10:04:09Z","timestamp":1747389849000},"page":"1083-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A clinical solution for tracking clonal evolution of acute myeloid leukemia after allogeneic transplantation using bulk next generation sequencing"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-3799","authenticated-orcid":false,"given":"Elizabeth F.","family":"Krakow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-3823","authenticated-orcid":false,"given":"Isaac","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Sala-Torra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Beppu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald P.","family":"Radich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7203-5261","authenticated-orcid":false,"given":"Bryce","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9767-9739","authenticated-orcid":false,"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia CS","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-825X","authenticated-orcid":false,"given":"Ivana","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2602_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bmt.2017.218","volume":"53","author":"N Kr\u00f6ger","year":"2018","unstructured":"Kr\u00f6ger N, Bishop M, Giralt S, Wayne A. Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation. Bone Marrow Transpl. 2018;53:1\u20132. https:\/\/doi.org\/10.1038\/bmt.2017.218","journal-title":"Bone Marrow Transpl"},{"key":"2602_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41409-018-0171-z","volume":"53","author":"M Horowitz","year":"2018","unstructured":"Horowitz M, Schreiber H, Elder A, Heidenreich O, Vormoor J, Toffalori C, et al. Epidemiology and biology of relapse after stem cell transplantation. Bone Marrow Transpl. 2018;53:1379\u201389. https:\/\/doi.org\/10.1038\/s41409-018-0171-z","journal-title":"Bone Marrow Transpl"},{"key":"2602_CR3","doi-asserted-by":"publisher","first-page":"e1004462","DOI":"10.1371\/journal.pgen.1004462","volume":"10","author":"AE Hughes","year":"2014","unstructured":"Hughes AE, Magrini V, Demeter R, Miller CA, Fulton R, Fulton LL, et al. Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing. PLoS Genet. 2014;10:e1004462. https:\/\/doi.org\/10.1371\/journal.pgen.1004462","journal-title":"PLoS Genet"},{"key":"2602_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccr.2014.01.031","volume":"25","author":"JM Klco","year":"2014","unstructured":"Klco JM, Spencer DH, Miller CA, Griffith M, Lamprecht T, O\u2019Laughlin M, et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell. 2014;25:379\u201392. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.031","journal-title":"Cancer Cell"},{"key":"2602_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41375-018-0319-2","volume":"33","author":"N Potter","year":"2019","unstructured":"Potter N, Miraki-Moud F, Ermini L, Titley I, Vijaraghavan G, Papaemmanuil E, et al. Single cell analysis of clonal architecture in acute myeloid leukaemia. Leukemia. 2019;33:1113\u201323. https:\/\/doi.org\/10.1038\/s41375-018-0319-2","journal-title":"Leukemia"},{"key":"2602_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1182\/bloodadvances.2019001181","volume":"4","author":"A Ediriwickrema","year":"2020","unstructured":"Ediriwickrema A, Aleshin A, Reiter JG, Corces MR, K\u00f6khnke T, Stafford M, et al. Single-cell mutational profiling enhances the clinical evaluation of AML MRD. Blood Adv. 2020;4:943\u201352. https:\/\/doi.org\/10.1182\/bloodadvances.2019001181","journal-title":"Blood Adv"},{"key":"2602_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020;11:5327. https:\/\/doi.org\/10.1038\/s41467-020-19119-8","journal-title":"Nat Commun"},{"key":"2602_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","volume":"587","author":"LA Miles","year":"2020","unstructured":"Miles LA, Bowman RL, Merlinsky TR, Csete IS, Ooi AT, Durruthy-Durruthy R, et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature. 2020;587:477\u201382. https:\/\/doi.org\/10.1038\/s41586-020-2864-x","journal-title":"Nature"},{"key":"2602_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/biomedicines12010066","volume":"12","author":"M Garc\u00eda-\u00c1lvarez","year":"2023","unstructured":"Garc\u00eda-\u00c1lvarez M, Yeguas A, Jim\u00e9nez C, Medina-Herrera A, Gonz\u00e1lez-Calle V, Hern\u00e1ndez-Ruano M, et al. Single-cell DNA sequencing and immunophenotypic profiling to track clonal evolution in an acute myeloid leukemia patient. Biomedicines. 2023;12:66. https:\/\/doi.org\/10.3390\/biomedicines12010066","journal-title":"Biomedicines"},{"key":"2602_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03919-2","volume":"21","author":"S Gillis","year":"2020","unstructured":"Gillis S, Roth A. PyClone-VI: scalable inference of clonal population structures using whole genome data. BMC Bioinforma. 2020;21:571. https:\/\/doi.org\/10.1186\/s12859-020-03919-2","journal-title":"BMC Bioinforma"},{"key":"2602_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0602-8","volume":"16","author":"AG Deshwar","year":"2015","unstructured":"Deshwar AG, Vembu S, Yung CK, Jang GH, Stein L, Morris Q. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 2015;16:35. https:\/\/doi.org\/10.1186\/s13059-015-0602-8","journal-title":"Genome Biol"},{"key":"2602_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41596-023-00913-9","volume":"19","author":"K Grigoriadis","year":"2024","unstructured":"Grigoriadis K, Huebner A, Bunkum A, Colliver E, Frankell AM, Hill MS, et al. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction. Nat Protoc. 2024;19:159\u201383. https:\/\/doi.org\/10.1038\/s41596-023-00913-9","journal-title":"Nat Protoc"},{"key":"2602_CR13","doi-asserted-by":"publisher","first-page":"e1003665","DOI":"10.1371\/journal.pcbi.1003665","volume":"10","author":"CA Miller","year":"2014","unstructured":"Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol. 2014;10:e1003665. https:\/\/doi.org\/10.1371\/journal.pcbi.1003665","journal-title":"PLoS Comput Biol"},{"key":"2602_CR14","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nprot.2018.033","volume":"13","author":"Y Cun","year":"2018","unstructured":"Cun Y, Yang TP, Achter V, Lang U, Peifer M. Copy-number analysis and inference of subclonal populations in cancer genomes using Sclust. Nat Protoc. 2018;13:1488\u2013501. https:\/\/doi.org\/10.1038\/nprot.2018.033","journal-title":"Nat Protoc"},{"key":"2602_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18169-2","volume":"11","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Wang X, Zhang H, Ulintz PJ, Li H, Guan Y. FastClone is a probabilistic tool for deconvoluting tumor heterogeneity in bulk-sequencing samples. Nat Commun. 2020;11:4469. https:\/\/doi.org\/10.1038\/s41467-020-18169-2","journal-title":"Nat Commun"},{"key":"2602_CR16","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.celrep.2014.04.055","volume":"7","author":"A Fischer","year":"2014","unstructured":"Fischer A, V\u00e1zquez-Garc\u00eda I, Illingworth CJR, Mustonen V. High-definition reconstruction of clonal composition in cancer. Cell Rep. 2014;7:1740\u201352. https:\/\/doi.org\/10.1016\/j.celrep.2014.04.055","journal-title":"Cell Rep."},{"key":"2602_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0647-8","volume":"16","author":"V Popic","year":"2015","unstructured":"Popic V, Salari R, Hajirasouliha I, Kashef-Haghighi D, West RB, Batzoglou S. Fast and scalable inference of multi-sample cancer lineages. Genome Biol. 2015;16:91. https:\/\/doi.org\/10.1186\/s13059-015-0647-8","journal-title":"Genome Biol"},{"key":"2602_CR18","doi-asserted-by":"publisher","first-page":"e1003703","DOI":"10.1371\/journal.pcbi.1003703","volume":"10","author":"H Zare","year":"2014","unstructured":"Zare H, Wang J, Hu A, Weber K, Smith J, Nickerson D, et al. Inferring clonal composition from multiple sections of a breast cancer. PLoS Comput Biol. 2014;10:e1003703. https:\/\/doi.org\/10.1371\/journal.pcbi.1003703","journal-title":"PLoS Comput Biol"},{"key":"2602_CR19","doi-asserted-by":"publisher","first-page":"E5528","DOI":"10.1073\/pnas.1522203113","volume":"113","author":"Y Jiang","year":"2016","unstructured":"Jiang Y, Qiu Y, Minn AJ, Zhang NR. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing. Proc Natl Acad Sci USA. 2016;113:E5528\u201337. https:\/\/doi.org\/10.1073\/pnas.1522203113","journal-title":"Proc Natl Acad Sci USA"},{"key":"2602_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03863-1","volume":"21","author":"G Caravagna","year":"2020","unstructured":"Caravagna G, Sanguinetti G, Graham TA, Sottoriva A. The MOBSTER R package for tumour subclonal deconvolution from bulk DNA whole-genome sequencing data. BMC Bioinforma. 2020;21:531. https:\/\/doi.org\/10.1186\/s12859-020-03863-1","journal-title":"BMC Bioinforma"},{"key":"2602_CR21","doi-asserted-by":"publisher","first-page":"i152","DOI":"10.1093\/bioinformatics\/btx270","volume":"33","author":"G Satas","year":"2017","unstructured":"Satas G, Raphael BJ. Tumor phylogeny inference using tree-constrained importance sampling. Bioinformatics. 2017;33:i152\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btx270","journal-title":"Bioinformatics"},{"key":"2602_CR22","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/bioinformatics\/bty016","volume":"34","author":"P Deveau","year":"2018","unstructured":"Deveau P, Colmet Daage L, Oldridge D, Bernard V, Bellini A, Chicard M, et al. QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction. Bioinformatics. 2018;34:1808\u201316. https:\/\/doi.org\/10.1093\/bioinformatics\/bty016","journal-title":"Bioinformatics"},{"key":"2602_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cels.2019.05.010","volume":"8","author":"MA Myers","year":"2019","unstructured":"Myers MA, Satas G, Raphael BJ. CALDER: inferring phylogenetic trees from longitudinal tumor samples. Cell Syst. 2019;8:514\u201322.e5. https:\/\/doi.org\/10.1016\/j.cels.2019.05.010","journal-title":"Cell Syst"},{"key":"2602_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/2643-3230.BCD-21-0092","volume":"3","author":"JA Wintersinger","year":"2022","unstructured":"Wintersinger JA, Dobson SM, Kulman E, Stein LD, Dick JE, Morris Q. Reconstructing complex cancer evolutionary histories from multiple bulk DNA samples using Pairtree. Blood Cancer Discov. 2022;3:208\u201319. https:\/\/doi.org\/10.1158\/2643-3230.BCD-21-0092","journal-title":"Blood Cancer Discov"},{"key":"2602_CR25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/bioinformatics\/btv003","volume":"31","author":"S Malikic","year":"2015","unstructured":"Malikic S, McPherson AW, Donmez N, Sahinalp CS. Clonality inference in multiple tumor samples using phylogeny. Bioinformatics. 2015;31:1349\u201356. https:\/\/doi.org\/10.1093\/bioinformatics\/btv003","journal-title":"Bioinformatics"},{"key":"2602_CR26","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1093\/bioinformatics\/btac367","volume":"38","author":"L Zheng","year":"2022","unstructured":"Zheng L, Niknafs N, Wood LD, Karchin R, Scharpf RB. Estimation of cancer cell fractions and clone trees from multi-region sequencing of tumors. Bioinformatics. 2022;38:3677\u201383. https:\/\/doi.org\/10.1093\/bioinformatics\/btac367","journal-title":"Bioinformatics"},{"key":"2602_CR27","doi-asserted-by":"publisher","first-page":"i62","DOI":"10.1093\/bioinformatics\/btv261","volume":"31","author":"M El-Kebir","year":"2015","unstructured":"El-Kebir M, Oesper L, Acheson-Field H, Raphael BJ. Reconstruction of clonal trees and tumor composition from multi-sample sequencing data. Bioinformatics. 2015;31:i62\u201370. https:\/\/doi.org\/10.1093\/bioinformatics\/btv261","journal-title":"Bioinformatics"},{"key":"2602_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-35","volume":"15","author":"W Jiao","year":"2014","unstructured":"Jiao W, Vembu S, Deshwar AG, Stein L, Morris Q. Inferring clonal evolution of tumors from single nucleotide somatic mutations. BMC Bioinforma. 2014;15:35. https:\/\/doi.org\/10.1186\/1471-2105-15-35","journal-title":"BMC Bioinforma"},{"key":"2602_CR29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","volume":"378","author":"M Jongen-Lavrencic","year":"2018","unstructured":"Jongen-Lavrencic M, Grob T, Hanekamp D, Kavelaars FG, Hinai AA, Zeilemaker A, et al. Molecular minimal residual disease in acute myeloid leukemia. N. Engl J Med. 2018;378:1189\u201399. https:\/\/doi.org\/10.1056\/NEJMoa1716863","journal-title":"N. Engl J Med"},{"key":"2602_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/leu.2017.200","volume":"32","author":"VI Gaidzik","year":"2018","unstructured":"Gaidzik VI, Weber D, Paschka P, Kaumanns A, Krieger S, Corbacioglu A, et al. DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia. Leukemia. 2018;32:30\u20137. https:\/\/doi.org\/10.1038\/leu.2017.200","journal-title":"Leukemia"},{"key":"2602_CR31","doi-asserted-by":"publisher","first-page":"e676","DOI":"10.1097\/HS9.0000000000000676","volume":"6","author":"JM Tettero","year":"2021","unstructured":"Tettero JM, Freeman S, Buecklein V, Venditti A, Maurollo L, Kern W, et al. Technical aspects of flow cytometry-based measurable residual disease quantification in acute myeloid leukemia: experience of the European LeukemiaNet MRD Working Party. Hemasphere. 2021;6:e676. https:\/\/doi.org\/10.1097\/HS9.0000000000000676","journal-title":"Hemasphere"},{"key":"2602_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.25665","volume":"95","author":"EF Krakow","year":"2020","unstructured":"Krakow EF, Gyurkocza B, Storer BE, Chauncey TR, McCune JS, Radich JP, et al. Phase I\/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia. Am J Hematol. 2020;95:48\u201356. https:\/\/doi.org\/10.1002\/ajh.25665","journal-title":"Am J Hematol"},{"key":"2602_CR33","unstructured":"Archer. Analysis 6.0 User Manual. https:\/\/cdn2.hubspot.net\/hubfs\/4445440\/CS001.C%20Archer%20Analysis%206.0%20User%20Manual.pdf. Accessed 24 Mar 2025."},{"key":"2602_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"key":"2602_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26698-7","volume":"12","author":"G Tanner","year":"2021","unstructured":"Tanner G, Westhead DR, Droop A, Stead LF. Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data. Nat Commun. 2021;12:6396. https:\/\/doi.org\/10.1038\/s41467-021-26698-7","journal-title":"Nat Commun"},{"key":"2602_CR36","unstructured":"Chang WC, Joe, Allaire J, Sievert C, Schloerke B, Xie Y. R-Shiny. https:\/\/CRAN.R-project.org\/package=shiny. Accessed 24 March 2025."},{"key":"2602_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"2602_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19:4\u201323. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.10.002","journal-title":"J Mol Diagn"},{"key":"2602_CR39","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","volume":"125","author":"RC Lindsley","year":"2015","unstructured":"Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125:1367\u201376. https:\/\/doi.org\/10.1182\/blood-2014-11-610543","journal-title":"Blood"},{"key":"2602_CR40","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/j.clml.2021.12.008","volume":"22","author":"J Song","year":"2022","unstructured":"Song J, Zhang H, Dong N, Zhang X, Hussaini M, Jain A, et al. The application of NextGen sequencing in the diagnosis of myeloid neoplasms in myeloma patients with cytopenia. Clin Lymphoma Myeloma Leuk. 2022;22:e414\u201326. https:\/\/doi.org\/10.1016\/j.clml.2021.12.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2602_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-022-01228-0","volume":"15","author":"A Padella","year":"2022","unstructured":"Padella A, Ghelli Luserna Di Ror\u00e0 A, Marconi G, Ghetti M, Martinelli G, Simonetti G. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. J Hematol Oncol. 2022;15:10. https:\/\/doi.org\/10.1186\/s13045-022-01228-0","journal-title":"J Hematol Oncol"},{"key":"2602_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41375-023-02072-y","volume":"38","author":"L Bischof","year":"2024","unstructured":"Bischof L, Ussmann J, Grimm J, Bill M, Brauer D, Backhaus D, et al. Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation. Leukemia. 2024;38:198\u2013201. https:\/\/doi.org\/10.1038\/s41375-023-02072-y","journal-title":"Leukemia"},{"key":"2602_CR43","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/sj.leu.2403468","volume":"18","author":"R Lamba","year":"2004","unstructured":"Lamba R, Abella E, Kukuruga D, Savasan S, Abidi MH, Mohamed A, et al. Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival. Leukemia. 2004;18:1681\u20136. https:\/\/doi.org\/10.1038\/sj.leu.2403468","journal-title":"Leukemia"},{"key":"2602_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1200\/JCO.20.02308","volume":"39","author":"C Craddock","year":"2021","unstructured":"Craddock C, Jackson A, Loke J, Siddique S, Hodgkinson A, Mason J, et al. Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia. J Clin Oncol. 2021;39:768\u201378. https:\/\/doi.org\/10.1200\/JCO.20.02308","journal-title":"J Clin Oncol"},{"key":"2602_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41409-022-01615-8","volume":"57","author":"H Lindahl","year":"2022","unstructured":"Lindahl H, Vonlanthen S, Valentini D, Bj\u00f6rklund AT, Sundin M, Mielke S, et al. Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Bone Marrow Transpl. 2022;57:753\u20139. https:\/\/doi.org\/10.1038\/s41409-022-01615-8","journal-title":"Bone Marrow Transpl"},{"key":"2602_CR46","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1200\/JCO.2004.05.198","volume":"22","author":"P Bader","year":"2004","unstructured":"Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P, et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol. 2004;22:1696\u2013705. https:\/\/doi.org\/10.1200\/JCO.2004.05.198","journal-title":"J Clin Oncol"},{"key":"2602_CR47","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/jha2.568","volume":"3","author":"H Lindahl","year":"2022","unstructured":"Lindahl H, Valentini D, Vonlanthen S, Sundin M, Bj\u00f6rklund AT, Mielke S, et al. Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis. EJHaem. 2022;3:1277\u201386. https:\/\/doi.org\/10.1002\/jha2.568","journal-title":"EJHaem"},{"key":"2602_CR48","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3324\/haematol.2022.280638","volume":"107","author":"C Saygin","year":"2022","unstructured":"Saygin C, Cannova J, Stock W, Muffly L. Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica. 2022;107:2783\u201393. https:\/\/doi.org\/10.3324\/haematol.2022.280638","journal-title":"Haematologica"},{"key":"2602_CR49","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/bjh.15086","volume":"180","author":"F Lovisa","year":"2018","unstructured":"Lovisa F, Zecca M, Rossi B, Campeggio M, Magrin E, Giarin E, et al. Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia. Br J Haematol. 2018;180:680\u201393. https:\/\/doi.org\/10.1111\/bjh.15086","journal-title":"Br J Haematol"},{"key":"2602_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7604","volume":"6","author":"X Ma","year":"2015","unstructured":"Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015;6:6604. https:\/\/doi.org\/10.1038\/ncomms7604","journal-title":"Nat Commun"},{"key":"2602_CR51","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00277-018-3554-8","volume":"98","author":"H Ishida","year":"2019","unstructured":"Ishida H, Iguchi A, Aoe M, Takahashi T, Tamefusa K, Kanamitsu K, et al. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing. Ann Hematol. 2019;98:657\u201368. https:\/\/doi.org\/10.1007\/s00277-018-3554-8","journal-title":"Ann Hematol"},{"key":"2602_CR52","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1158\/1078-0432.CCR-23-1674","volume":"30","author":"G Qin","year":"2024","unstructured":"Qin G, Dai J, Chien S, Martin TJ, Loera B, Nguyen QH, et al. Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia. Clin Cancer Res. 2024;30:2659\u201371. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1674. 14","journal-title":"Clin Cancer Res"},{"key":"2602_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14:91. https:\/\/doi.org\/10.1186\/s13045-021-01105-2","journal-title":"J Hematol Oncol"},{"key":"2602_CR54","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41588-021-00873-4","volume":"53","author":"A Sarkar","year":"2021","unstructured":"Sarkar A, Stephens M. Separating measurement and expression models clarifies confusion in single-cell RNA sequencing analysis. Nat Genet. 2021;53:770\u201377. https:\/\/doi.org\/10.1038\/s41588-021-00873-4","journal-title":"Nat Genet"},{"key":"2602_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27472-5","volume":"12","author":"BA Benard","year":"2021","unstructured":"Benard BA, Leak LB, Azizi A, Thomas D, Gentles AJ, Majeti R. Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia. Nat Commun. 2021;12:7244. https:\/\/doi.org\/10.1038\/s41467-021-27472-5","journal-title":"Nat Commun"},{"key":"2602_CR56","doi-asserted-by":"publisher","first-page":"281re2","DOI":"10.1126\/scitranslmed.aaa0763","volume":"7","author":"AL Paguirigan","year":"2015","unstructured":"Paguirigan AL, Smith J, Meshinchi S, Carroll M, Maley C, Radich JP. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia. Sci Transl Med. 2015;7:281re2. https:\/\/doi.org\/10.1126\/scitranslmed.aaa0763","journal-title":"Sci Transl Med"},{"key":"2602_CR57","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41591-021-01558-5","volume":"27","author":"T Hernandez-Boussard","year":"2021","unstructured":"Hernandez-Boussard T, Macklin P, Greenspan EJ, Gryshuk AL, Stahlberg E, Syeda-Mahmood T, et al. Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat Med. 2021;27:2065\u201366. https:\/\/doi.org\/10.1038\/s41591-021-01558-5","journal-title":"Nat Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02602-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:04:42Z","timestamp":1754413482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02602-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2602"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02602-5","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors EFK, NL, IB, IJ, JR, OST and CY are inventors of patent applications filed by FHCC directed to the system for tracking cancer clones alongside clinical data as described in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}